A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on:

Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment
Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines
Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease
Letters and medicine recalls sent to healthcare professionals in April 2023.

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.

The post MHRA Drug Safety Update May 2023 appeared first on PSNC Website.